Header image

EUROPE’S BIOTECH MOMENT: WHAT THE BIOTECH ACT MUST DELIVER

Tracks
AUDITORIUM MARGARITA SALAS
Tuesday, September 29, 2026
12:15 - 13:00
AUDITORIUM MARGARITA SALAS

Overview

Sponsor: MSD


Details

The year 2025 has been marked by the Biotech Act, the proposed Regulation through which the European Commission aims to establish a comprehensive regulatory framework to foster investment, innovation, and competitiveness in the biotechnology sector at a pivotal moment for Europe's strategic autonomy. Against this backdrop, this session will explore how the Biotech Act represents an opportunity to strengthen the competitiveness of the Spanish biotechnology sector. In particular, the discussion will focus on some of the proposals expected to have the greatest impact on the industry, including Strategic Projects, financing pilots, the extension of the Supplementary Protection Certificate (SPC), and measures to accelerate clinical trials.


Speaker

Agenda Item Image
Laura Pellisé
Government Affairs Director of Amgen & Member of the Board of AseBio
Amgen / AseBio

Moderator

Agenda Item Image
Cristina Nadal Sanmartin
President of AseBio and Executive Director of Policy of MSD Spain
AseBio / MSD

.

Agenda Item Image
Raquel Yotti
Comissioner for Avant-Garde Health
Ministry of Science, Innovation and Universities

.

Agenda Item Image
Javier Padilla Benáldez
Secretary of State
Ministry of Health

.

Agenda Item Image
Thomas Van Cangh
Deputy Head of Unit - Head of Biotech Taskforce
DG SANTE

.

loading